Oral Antibiotic Regimens for Pneumonia
Outpatient Community-Acquired Pneumonia (CAP)
For otherwise healthy adults without comorbidities, amoxicillin 1 g three times daily is the preferred first-line oral antibiotic, with doxycycline 100 mg twice daily as an alternative. 1
Healthy Adults (No Comorbidities)
Preferred regimens:
- Amoxicillin 1 g orally every 8 hours (strong recommendation based on proven efficacy in inpatient CAP studies and excellent safety profile) 1
- Doxycycline 100 mg orally twice daily (consider 200 mg first dose for faster therapeutic levels) 1
Alternative regimen:
- Macrolide monotherapy (azithromycin 500 mg day 1, then 250 mg daily days 2-5; or clarithromycin 500 mg twice daily) - only in areas where pneumococcal macrolide resistance is <25% 1
Adults with Comorbidities
For patients with chronic heart, lung, liver, or renal disease; diabetes; alcoholism; malignancy; or asplenia, combination therapy or respiratory fluoroquinolone monotherapy is recommended. 1
Combination therapy options:
- Amoxicillin-clavulanate 875/125 mg twice daily OR 2,000/125 mg twice daily PLUS azithromycin (500 mg day 1, then 250 mg daily) or doxycycline 100 mg twice daily 1
- Cefpodoxime 200 mg twice daily OR cefuroxime 500 mg twice daily PLUS macrolide or doxycycline 1
Monotherapy option:
Pathogen-Specific Oral Regimens
Streptococcus pneumoniae (Penicillin MIC <2)
Preferred:
- Amoxicillin 1 g orally every 8 hours 1
Alternatives:
Mycoplasma pneumoniae
Preferred:
- Doxycycline 100 mg orally twice daily for 7-14 days 1
- Minocycline 200 mg loading dose, then 100 mg twice daily for 7-14 days 1
Alternatives:
- Azithromycin 500 mg day 1, then 250 mg daily for 4 days 1
- Levofloxacin 750 mg daily for 7-14 days 1
- Moxifloxacin 400 mg daily for 7-14 days 1
Chlamydophila pneumoniae
Preferred:
- Azithromycin 500 mg day 1, then 250 mg daily for 4 days 1
Alternatives:
- Clarithromycin 500 mg twice daily for 10 days 1
- Doxycycline 100 mg twice daily for 10 days 1
- Levofloxacin 500-750 mg daily for 7-10 days 1
Legionella species
Preferred:
Alternatives:
- Azithromycin 1000 mg IV day 1, then 500 mg orally daily 1
Haemophilus influenzae
β-lactamase negative:
- Amoxicillin 1 g every 8 hours 1
β-lactamase positive:
- Amoxicillin-clavulanate 875/125 mg twice daily 1
Staphylococcus aureus (Methicillin-susceptible)
Alternatives for oral therapy:
- Amoxicillin-clavulanate 875/125 mg three times daily 1
- Levofloxacin 750 mg daily 1
- Clindamycin 600 mg every 8 hours 1
Staphylococcus aureus (Methicillin-resistant)
Oral option:
- Linezolid 600 mg twice daily 1
Treatment Duration
For patients achieving clinical stability, treatment duration should be minimized to reduce antibiotic resistance. 1, 2
- Standard CAP: 5 days for levofloxacin 750 mg regimen 1, 2; 5-7 days for other regimens if clinically stable 1
- Azithromycin: 3-5 days depending on formulation 3, 4, 5
- Atypical pathogens: 7-14 days for Mycoplasma/Chlamydia 1
- Treatment should not exceed 8 days in responding patients 2
Clinical stability criteria (must be afebrile for 48 hours AND meet all of the following): temperature ≤37.8°C, heart rate ≤100 bpm, respiratory rate ≤24 breaths/min, systolic BP ≥90 mmHg, oxygen saturation ≥90%, ability to maintain oral intake, normal mental status 1
Pediatric Oral Regimens (≥6 months)
Community-Acquired Pneumonia
Preferred:
- Amoxicillin 75-100 mg/kg/day in 3 divided doses (if β-lactamase negative pathogens) 1
- Amoxicillin-clavulanate 45 mg/kg/day in 3 doses OR 90 mg/kg/day in 2 doses (if β-lactamase producing) 1
For atypical pathogens:
Mycoplasma/Chlamydia in Children
Preferred:
- Azithromycin 10 mg/kg day 1, then 5 mg/kg daily days 2-5 1
Alternatives:
- Clarithromycin 15 mg/kg/day in 2 doses 1
- Doxycycline 2-4 mg/kg/day in 2 doses (for children >7 years) 1
Critical Warnings and Contraindications
Fluoroquinolone Precautions
Avoid fluoroquinolones in patients with:
- History of QT prolongation, torsades de pointes, or congenital long QT syndrome 3
- Uncorrected hypokalemia or hypomagnesemia 3
- Concurrent use of Class IA or III antiarrhythmics 3
- Recent fluoroquinolone exposure (resistance risk) 2
- Vascular disease or elderly patients (increased adverse event risk) 1
Macrolide Warnings
Azithromycin carries risk of:
- QT prolongation and cardiac arrhythmias (similar precautions as fluoroquinolones) 3
- Hepatotoxicity requiring immediate discontinuation if hepatitis signs develop 3
- Should only be used where pneumococcal macrolide resistance is <25% 1
Clostridium difficile Risk
All antibiotics carry risk of C. difficile-associated diarrhea; maintain high suspicion if diarrhea develops during or up to 2 months after treatment. 3
Common Pitfalls
- Do not use macrolide monotherapy in areas with high pneumococcal resistance (≥25%) - this increases treatment failure risk 1
- Do not use fluoroquinolones as first-line in healthy patients without comorbidities - reserve for appropriate risk groups to minimize resistance and adverse events 1
- Do not continue antibiotics beyond clinical stability plus 48 hours afebrile - prolonged courses increase resistance without improving outcomes 1, 2
- Do not assume oral therapy is appropriate for severe pneumonia - patients with hypoxemia, hemodynamic instability, inability to take oral medications, or high-risk features require hospitalization and IV therapy 3